Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38
United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
John P. Butler
6 Aug 2026
CEO and President
Exercised, kept
350,000
$0.63
$220.50K
Ron Frieson
17 Jan 2025
Director
Exercised, kept
20,100
$0.45
$9.05K
John P. Butler
3 Jun 2019
CEO and President
Exercised, kept
287,000
$0.47
$134.89K
John P. Butler
11 Jul 2018
CEO and President
Exercised, kept
100,000
$0.47
$47.00K
John P. Butler
19 Jan 2017
CEO and President
Exercised, kept
20,000
$0.47
$9.40K

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 1
Sales at will 96
Transactions with no price 0
Shares from compensation/vesting 12,885,944
Sales filed before the plan box existed 83
History held since 26 Mar 2014